Sarabia, Naomi A.
HRN: 26-09-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/31/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/31/2024
11/07/2024
IV
4.5g
Q8
DM Foot
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes